Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.64 USD | +0.09% | -4.16% | -77.84% |
05-31 | Biohaven Insider Bought Shares Worth $996,240, According to a Recent SEC Filing | MT |
05-15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-77.84% | 541M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Biohaven Granted US FDA Fast Track Designation for Spinal Muscular Atrophy Treatment Candidate